标题
CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
作者
关键词
-
出版物
Biomed Research International
Volume 2014, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2014-01-30
DOI
10.1155/2014/361020
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems
- (2015) Teddy S Nagaria et al. NEOPLASIA
- Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance
- (2013) M Kaliszczak et al. BRITISH JOURNAL OF CANCER
- Identification of small molecule inhibitors of p27Kip1ubiquitination by high-throughput screening
- (2013) Li-Ching Ooi et al. CANCER SCIENCE
- Cell cycle regulation by long non-coding RNAs
- (2013) Masatoshi Kitagawa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
- (2013) Prithviraj Bose et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1and p16INK4a
- (2013) Simona Giglio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors
- (2013) Tomáš Gucký et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Inhibitors of Cyclin-Dependent Kinases Combat Hepatocellular Carcinoma without Inducing Chemoresistance
- (2013) C. Haider et al. MOLECULAR CANCER THERAPEUTICS
- Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo
- (2013) S C Chiu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy
- (2012) M. F. Segura et al. CARCINOGENESIS
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
- (2010) Elodie E. Noel et al. AMERICAN JOURNAL OF PATHOLOGY
- p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
- (2010) S. A. Wander et al. CLINICAL CANCER RESEARCH
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
- (2010) S Wu et al. ONCOGENE
- Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysis
- (2010) P Bonelli et al. PHARMACOGENOMICS JOURNAL
- Anti-tumor activity of noble indirubin derivatives in human solid tumor models In Vitro
- (2009) Soo-Hyun Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells
- (2009) M. Redpath et al. BRITISH JOURNAL OF DERMATOLOGY
- A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3′ enhancers does not promote by itself B-cell malignancies
- (2009) Rémi Fiancette et al. LEUKEMIA RESEARCH
- NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells
- (2009) M. John-Aryankalayil et al. MOLECULAR CANCER THERAPEUTICS
- Cell cycle kinases as therapeutic targets for cancer
- (2009) Silvia Lapenna et al. NATURE REVIEWS DRUG DISCOVERY
- E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
- (2008) Fabio Petrocca et al. CANCER CELL
- Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
- (2008) A W Tong et al. CANCER GENE THERAPY
- Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling
- (2008) Hui Zhou et al. CANCER LETTERS
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma
- (2008) Yasunobu Matsuda WORLD JOURNAL OF GASTROENTEROLOGY
- Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas
- (2007) S. Fujiwara et al. DISEASES OF THE ESOPHAGUS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started